The efficacy of swicthing from sulfonyl urea to the combination therapy with mitiglinide and voglibose on diurnal variation on glycemic control and endothelial function in patients with type 2 diabetes

Trial Profile

The efficacy of swicthing from sulfonyl urea to the combination therapy with mitiglinide and voglibose on diurnal variation on glycemic control and endothelial function in patients with type 2 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Mitiglinide (Primary) ; Voglibose (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jul 2016 Status changed from recruiting to completed.
    • 14 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top